Search

Displaying results 1 - 10 of 58 in total
DrugBest match

Hyaluronidase (human recombinant)

go.drugbank.com/drugs/DB06205
ApprovedInvestigational

A purified preparation of the enzyme recombinant human hyaluronidase. Hyaluronidase (human recombinant) (INN Vorhyaluronidase alfa) is produced by genetically engineered Chinese Hamster Ovary (CHO) cells containing a DNA plasmid encoding for a soluble fragment of human hyaluronidase (PH20). Hyaluronidase is an enzym...

  1. Drug

    Human immunoglobulin G

    go.drugbank.com/drugs/DB00028
    ApprovedInvestigational

    IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population. … Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation.

    Synonyms: Human IGG, Human gammaglobulinCategories: Human Immunoglobulin G
  2. Drug

    Pegvorhyaluronidase alfa

    go.drugbank.com/drugs/DB14912
    Investigational

    Pegvorhyaluronidase alfa is under investigation in clinical trial NCT02241187 (Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection).

    Synonyms: PEGylated recombinant human hyaluronidase PH20, HUMAN HYALURONIDASE PH-20 (HYALURONOGLUCOSAMINIDASE PH-20, SPERM ADHESION MOLECULE 1, EC 3.2.1.35) PRECURSOR-(36-482)-PEPTIDE (MATURE (1-447)-PEPTIDE), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM
  3. Drug

    Berahyaluronidase alfa

    go.drugbank.com/drugs/DB22790
    ApprovedInvestigational

    Berahyaluronidase alfa is a recombinant variant of human hyaluronidase designed to enhance dispersion and permeation of subcutaneously co-administered drugs.

    Categories: Hyaluronidases, Recombinant Proteins
  4. Drug

    Efgartigimod alfa

    go.drugbank.com/drugs/DB15270
    ApprovedInvestigational

    [L43190] A formulation for subcutaneous use that combines efgartigimod alfa and hyaluronidase was later approved for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP

    Categories: Human Immunoglobulin G
  5. Indication

    Secondary humoral immunodeficiency

    go.drugbank.com/conditions/DBCOND0150607
    Drugs: Human immunoglobulin G · Hyaluronidase (human recombinant)
  6. Indication

    Advanced Esophageal Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0129586
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  7. Indication

    Advanced Gastric Carcinoma

    go.drugbank.com/conditions/DBCOND0032323
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  8. Indication

    Completely resected Stage IIB melanoma

    go.drugbank.com/conditions/DBCOND0160974
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  9. Indication

    Completely resected Stage III melanoma

    go.drugbank.com/conditions/DBCOND0160976
    Drugs: Hyaluronidase (human recombinant) · Nivolumab